
LINCOLNLincoln Pharmaceuticals Ltd.
Lincoln Pharmaceuticals Q2 FY27 Results: Consolidated Net Profit ₹20.43 Crore on Total Income of ₹201 Crore
Lincoln Pharmaceuticals (NSE: LINCOLN) reported total income of ₹200.88 crore and net profit of ₹20.43 crore for the quarter ended 30 Sep 2026, on both a consolidated and a standalone basis, it said in a filing on 29 Oct 2026.
- Earnings
- pharmaceuticals